PH12018500271A1 - A percutaneous absorption composition - Google Patents

A percutaneous absorption composition

Info

Publication number
PH12018500271A1
PH12018500271A1 PH12018500271A PH12018500271A PH12018500271A1 PH 12018500271 A1 PH12018500271 A1 PH 12018500271A1 PH 12018500271 A PH12018500271 A PH 12018500271A PH 12018500271 A PH12018500271 A PH 12018500271A PH 12018500271 A1 PH12018500271 A1 PH 12018500271A1
Authority
PH
Philippines
Prior art keywords
basic
sorbic acid
basic drug
preferred
percutaneous absorption
Prior art date
Application number
PH12018500271A
Other languages
English (en)
Inventor
Yasushi Miwa
Hidetoshi Hamamoto
Naoya AKAZAWA
Original Assignee
Medrx Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medrx Co Ltd filed Critical Medrx Co Ltd
Publication of PH12018500271A1 publication Critical patent/PH12018500271A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PH12018500271A 2015-08-29 2018-02-06 A percutaneous absorption composition PH12018500271A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/JP2015/074553 WO2017037813A1 (ja) 2015-08-29 2015-08-29 塩基性薬物とソルビン酸とを含有する経皮吸収組成物
PCT/JP2016/075203 WO2017038767A1 (ja) 2015-08-29 2016-08-29 経皮吸収組成物

Publications (1)

Publication Number Publication Date
PH12018500271A1 true PH12018500271A1 (en) 2018-08-13

Family

ID=58187853

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12018500271A PH12018500271A1 (en) 2015-08-29 2018-02-06 A percutaneous absorption composition

Country Status (15)

Country Link
EP (1) EP3342423B1 (enrdf_load_stackoverflow)
JP (2) JP6259117B2 (enrdf_load_stackoverflow)
KR (1) KR20180039622A (enrdf_load_stackoverflow)
CN (1) CN107427509B (enrdf_load_stackoverflow)
BR (1) BR112018001387B8 (enrdf_load_stackoverflow)
CO (1) CO2018001831A2 (enrdf_load_stackoverflow)
ES (1) ES2864017T3 (enrdf_load_stackoverflow)
MX (1) MX388148B (enrdf_load_stackoverflow)
MY (1) MY189987A (enrdf_load_stackoverflow)
PH (1) PH12018500271A1 (enrdf_load_stackoverflow)
RU (1) RU2702356C2 (enrdf_load_stackoverflow)
SG (1) SG11201800043UA (enrdf_load_stackoverflow)
UA (1) UA123212C2 (enrdf_load_stackoverflow)
WO (2) WO2017037813A1 (enrdf_load_stackoverflow)
ZA (1) ZA201800296B (enrdf_load_stackoverflow)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019151423A1 (ja) * 2018-01-31 2019-08-08 株式会社 メドレックス チザニジン治療システム
TWI772807B (zh) * 2019-05-27 2022-08-01 日商救急藥品工業股份有限公司 外用製劑
EP4415696A1 (en) * 2021-10-15 2024-08-21 LTS Lohmann Therapie-Systeme AG Transdermal therapeutic system for the transdermal administration of tizanidine
CN116370439A (zh) * 2022-04-01 2023-07-04 江苏山信药业有限公司 一种伐尼克兰透皮贴剂及其制备方法和其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61172830A (ja) * 1985-01-26 1986-08-04 Showa Denko Kk 皮膚外用剤組成物
US20040142024A1 (en) * 1999-07-27 2004-07-22 Hisamitsu Pharmaceutical Co., Inc. Patch formulation for external use
CN1222281C (zh) * 1999-07-27 2005-10-12 久光制药株式会社 外用贴剂
EP1729746B1 (en) * 2004-03-19 2009-11-18 McNeil AB Means for transdermal administration of nicotine
JP4807974B2 (ja) * 2005-06-30 2011-11-02 帝國製薬株式会社 経皮吸収促進組成物
CN101032474B (zh) * 2006-03-06 2011-02-16 重庆医药工业研究院有限责任公司 一种治疗或预防神经系统疾病的雷沙吉兰透皮贴片及其制备方法
CN101143127A (zh) * 2007-10-25 2008-03-19 复旦大学 一种酚妥拉明外用制剂及其制备方法
KR101514342B1 (ko) * 2007-11-22 2015-04-22 가부시키가이샤 메드렉스 지방산계 이온 액체를 유효성분으로 하는 외용제 조성물
US8580281B2 (en) * 2008-02-27 2013-11-12 Hisamitsu Pharmaceutical Co., Inc. Medicated patch
JP2012158521A (ja) * 2009-04-17 2012-08-23 Kureha Corp 外用剤
US9168232B2 (en) * 2009-09-07 2015-10-27 Nipro Patch Co., Ltd. Transdermally absorbable preparation
AU2011267348A1 (en) * 2010-06-18 2012-10-25 Merz Pharma Gmbh & Co. Kgaa Gel formulations for the topical use of 1-amino-alkylcyclohexane derivatives
CN108553452A (zh) * 2012-06-20 2018-09-21 美德阿利克斯株式会社 通过掺混药物、有机溶剂、亲脂性基质和粉末获得的粘附制剂组合物

Also Published As

Publication number Publication date
WO2017038767A1 (ja) 2017-03-09
JPWO2017038767A1 (ja) 2017-09-07
MX388148B (es) 2025-03-19
UA123212C2 (uk) 2021-03-03
MY189987A (en) 2022-03-22
WO2017037813A1 (ja) 2017-03-09
RU2018110617A3 (enrdf_load_stackoverflow) 2019-09-30
JP6259117B2 (ja) 2018-01-10
CN107427509A (zh) 2017-12-01
ZA201800296B (en) 2019-04-24
SG11201800043UA (en) 2018-02-27
CN107427509B (zh) 2021-06-15
KR20180039622A (ko) 2018-04-18
JP2017149782A (ja) 2017-08-31
BR112018001387A2 (pt) 2018-09-11
EP3342423A1 (en) 2018-07-04
ES2864017T3 (es) 2021-10-13
BR112018001387B1 (pt) 2023-09-05
MX2018002015A (es) 2018-06-19
RU2702356C2 (ru) 2019-10-08
BR112018001387B8 (pt) 2024-03-05
EP3342423A4 (en) 2018-07-25
RU2018110617A (ru) 2019-09-30
CO2018001831A2 (es) 2018-05-21
EP3342423B1 (en) 2021-03-10

Similar Documents

Publication Publication Date Title
SA520411125B1 (ar) Nlrp مركبات وتركيبات لمعالجة حالات مرضية مرتبطة بنشاط
PH12018500271A1 (en) A percutaneous absorption composition
MX2020010344A (es) Mezcla fertilizante que contiene inhibidor de la nitrificacion.
EA201690287A1 (ru) 1,4-дизамещенные аналоги пиридазин хинолина и способы лечения состояний, связанных с smn-дефицитом
BR112018005194A2 (pt) processo de composto antifúngico
MX373330B (es) Composiciones y métodos que comprenden bupropion o compuestos relacionados y dextrometorfano.
PH12016500511A1 (en) Selective grp94 inhibitors and uses thereof
PH12015501957A1 (en) Pharmaceutical composition of s-ketamine hydrochloride
EA201690598A1 (ru) Аминогетероарил бензамиды в качестве ингибиторов киназы
PH12015502013B1 (en) Pharmaceutical composition of s-ketamine hydrochloride
BR112015026297A2 (pt) terapia combinada composta por um inibidor tor quinase e um composto de 5-quinazolinona substituído para o tratamento de câncer
BR112015029495A2 (pt) compostos heterocíclicos como inibidores da via de sinalização hedgehog
PH12017501297B1 (en) Cyclic amine derivative and pharmaceutical use thereof
EP3398947A4 (en) NITROGENIC CONDENSED HETEROCYCLIC COMPOUND, AND MANUFACTURING METHOD, INTERMEDIATE PRODUCTS, COMPOSITION, AND APPLICATION THEREOF
MX2016004741A (es) Composicion farmaceutica que comprende un antagonista de trpa1 y un agente analgesico.
PH12016502352A1 (en) Pharmaceutical composition
PH12016502130B1 (en) Novel pyrrolopyrimidine compound or salt thereof, pharmaceutical composition containing same, especially agent for prevention and/or treatment of tumors etc based on nae inhibitory effect
AU2016216741A1 (en) Compositions and methods of use of an inappetance-controlling compound
MX2021015514A (es) Compuesto heterociclico.
MX2016016404A (es) Metodos para el tratamiento del prurito.
MX336765B (es) Composiciones de alta penetracion y metodos para tratar lesiones en los tejidos inducidas por agentes patogenos.
EA033769B9 (ru) Отселектированный амид -гидроксимасляной кислоты и его применения при лечении злоупотребления алкоголем
MX2019015747A (es) Compuesto heterociclico.
MX365021B (es) Composicion para tratar o prevenir enfermedades ocasionadas por permeabilidad vascular, que contiene como ingrediente activo imatinib o una sal farmaceuticamente aceptable del mismo.
WO2014201083A3 (en) Phenoxybenzamine transdermal composition